Headache News

DENVER — For those diagnosed with migraine, gastrointestinal issues or both, psychiatric comorbidities increase the risk of worsened physical and mental states, according to an expert at the American Academy of Neurology annual meeting.

DENVER — Lidocaine injection in the occipital region for young persons with acute migraine significantly increased pain relief compared with saline injections, according to research presented at the American Academy of Neurology annual meeting.

DENVER — A panel of four experts discussed different aspects of the ways brain health and climate change are linked at the American Academy of Neurology annual meeting.

DENVER — Children from underrepresented groups with migraine received fewer diagnoses, imaging, tests and medication compared with their white counterparts, according to a poster at the American Academy of Neurology annual meeting.

DENVER — For those experiencing chronic migraine, the presence of self-reported psychiatric conditions did not affect the effectiveness of eptinezumab, according to a poster at the American Academy of Neurology annual meeting.

DENVER — The concomitant use of atogepant for preventive and ubrogepant for acute migraine treatment was found to be safe and well-tolerated over 12 weeks, according to research presented at the American Academy of Neurology annual meeting.

DENVER — Among a large cohort of Danish citizens, headache disorders were strongly associated with attempted and completed suicide, according to a presenter at the American Academy of Neurology annual meeting.

Treatment with atogepant 60mg once daily significantly reduced monthly migraine days at 12 weeks compared with oral rimegepant 75mg every other day, according to research published in Cephalalgia.

Nontraditional risk factors such as migraine, valvular heart disease and thrombophilia may be linked to increased risk for stroke among younger adults, researchers reported.

NEW YORK — Patients with moderate to severe headache experienced a clinically significant reduction in headache symptoms after wearing Neurolens contoured prism technology, a company executive said at Vision Expo East.